IDO expression in various histologic cancer types seemed to build an immune-suppressive microenvironment (118, 119) by regulating immune cells including T effector cells (120), regulatory T cells (121), and Myeloid-derived suppressors cells (MDSC) (122, 123). The gene discussed is IDO1; the disease is cancer.